Skip to main content

Table 1 Socio-demographic and clinical characteristics of new pulmonary tuberculosis patients in Anqing, China, 2005–2013 (n = 22,998)

From: Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study

Variables

Total (n = 22,998)

PTB+ (n = 14,842)

PTB- (n = 8156)

χ 2

P

Sex

Female

6059 (26.35)

3793 (25.56)

2266 (27.78)

13.46

< 0.001

Male

16,939 (73.65)

11,049 (74.44)

5890 (72.22)

Age

15~ 24

3197 (13.90)

1960 (13.21)

1237 (15.17)

54.30

< 0.001

25~ 34

2281 (9.92)

1567 (10.56)

714 (8.75)

35~ 44

3601 (15.66)

2412 (16.25)

1189 (14.58)

45~ 54

3615 (15.72)

2340 (15.77)

1275 (15.63)

55~ 65

5013(21.80)

3269 (22.03)

1744 (21.38)

≥65

5291 (23.01)

3294 (22.19)

1997 (24.49)

Ethnicity

Han

22,960 (99.83)

14,819 (99.85)

8141 (99.82)

0.27

0.61

Other

38 (0.17)

23 (0.15)

15 (0.18)

Occupation

Student

1414 (6.15)

807 (5.44)

607 (7.44)

115.29

< 0.001

Official staff

356 (1.55)

190 (1.28)

166 (2.04)

Service

437 (1.90)

277 (1.87)

160 (1.96)

Worker

1897 (8.25)

1214 (8.18)

683 (8.37)

Farmer

17,507 (76.12)

11,567 (77.93)

5940 (72.83)

Retired staff

433 (1.88)

261 (1.76)

172 (2.11)

Unemployment

338 (1.47)

198 (1.33)

140 (1.72)

Other

616 (2.68)

328 (2.21)

288 (3.53)

X-Ray

Normal

408 (1.77)

286 (1.93)

122 (1.50)

14.35

< 0.001

Abnormal

22,447 (97.60)

14,447 (97.34)

8000 (98.09)

Unchecked

143 (0.62)

109 (0.73)

34 (0.42)

Cavity

Yes

3210 (13.96)

2527 (17.03)

683 (8.37)

328.07

< 0.001

No

19,788 (86.04)

12,315 (82.97)

7473 (91.63)

Miliary shadow

Yes

169 (0.73)

99 (0.67)

70 (0.86)

2.64

0.10

No

22,829 (99.27)

14,743 (99.33)

8086 (99.14)

Regimen

Regimen1a

17,581 (76.45)

12,470 (84.02)

5111 (62.67)

1332.81

< 0.001

Regimen 2b

5417 (23.55)

2372 (15.98)

3045 (37.33)

  1. PTB+: Smear-positive pulmonary tuberculosis patients
  2. PTB-: Smear-negative pulmonary tuberculosis patients
  3. a2H3R3Z3E3/4H3R3. R = rifampicin; H = isoniazid; Z = pyrazinamide; E = ethambutol. It means once-every-other-day HRZE for 2 months followed by 4 months of once-every-other-day HR
  4. b2HRZE/4HR. It means daily HRZE for 2 months followed by 4 months of daily HR.